DeHeng Hong Kong and Beijing Offices assisted Hong Kong Pharma Digital Technology Holdings Limited to complete the listing on Nasdaq

2025-01-20

Recently, DeHeng Hong Kong and Beijing offices assisted Hong Kong Pharma Digital Technology Holdings Limited to complete the listing on Nasdaq. On 20 December 2024, Hong Kong Pharma Digital Technology Holdings Limited (as the issuer) received the notice of effectiveness from the SEC in respect of the registration of its Ordinary Shares. On 15 January 2025, Hong Kong Pharma Digital Technology Holdings Limited completed the listing of its Ordinary Shares on Nasdaq (Stock Code: HKPD). The issuer is incorporated in the Cayman Islands, and is primarily engaged in the provision of cross-border pharmaceutical products supply chain services through its Hong Kong subsidiaries. It is a logistics solution partner of a number of renowned logistics and e-commerce platforms such as Cainiao.

DeHeng Hong Kong office acted as the issuer’s Hong Kong counsel in this transaction. Led by partner Howard Lau and supported by trainee solicitor Dicky Lau, DeHeng Hong Kong office provided comprehensive, efficient and professional services to the client throughout the course of the transaction. 

As the issuer’s PRC counsel, DeHeng Beijing office also advised on various specific PRC legal matters. The team was led by partner Zhang Xiaodan and supported by lawyer Yu Xinqian.